Prostate cancer with histone modifier UTX mutations can benefit from olaparib

被引：0
|
作者：
Muramoto, N. [1 ]
Iwasaki, M. [2 ]
Sera, Y. [2 ]
Ide, H. [1 ]
Horie, S. [1 ]
Honda, H. [2 ]
机构：
[1] Juntendo Univ, Urol, Grad Sch Med, Bunkyo ku, Tokyo, Japan
[2] Tokyo Womens Med Univ, Inst Lab Anim, Tokyo, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.10.397
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
271P
引用
收藏
页码：S1578 / S1579
页数：2
相关论文
共 50 条
  • [21] Which patients with prostate cancer benefit from immediate postoperative radiotherapy?
    Cox, B.
    Zelefsky, M. J.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2008, 5 (05): : 246 - 247
  • [22] Is there a benefit from lycopene supplementation in men with prostate cancer? A systematic review
    Haseen, F.
    Cantwell, M. M.
    O'Sullivan, J. M.
    Murray, L. J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2009, 12 (04) : 325 - 332
  • [23] Which patients with prostate cancer benefit from immediate postoperative radiotherapy?
    Brett Cox
    Michael J Zelefsky
    Nature Clinical Practice Oncology, 2008, 5 : 246 - 247
  • [24] What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments?
    Zhao, Li-Tao
    Liu, Zhen-Yu
    Xie, Wan-Fang
    Shao, Li-Zhi
    Lu, Jian
    Tian, Jie
    Liu, Jian-Gang
    MILITARY MEDICAL RESEARCH, 2023, 10 (01)
  • [25] What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments?
    Li-Tao Zhao
    Zhen-Yu Liu
    Wan-Fang Xie
    Li-Zhi Shao
    Jian Lu
    Jie Tian
    Jian-Gang Liu
    Military Medical Research, 10
  • [26] What benefit can be obtained from magnetic resonance imaging diagnosis with artificial intelligence in prostate cancer compared with clinical assessments?
    Li-Tao Zhao
    Zhen-Yu Liu
    Wan-Fang Xie
    Li-Zhi Shao
    Jian Lu
    Jie Tian
    Jian-Gang Liu
    Military Medical Research, 2024, 11 (02) : 268 - 286
  • [27] K-ras mutations and benefit from cetuximab in advanced colorectal cancer
    Karapetis, Christos S.
    Khambata-Ford, Shirin
    Jonker, Derek J.
    O'Callaghan, Chris J.
    Tu, Dongsheng
    Tebbutt, Niall C.
    Simes, R. John
    Chalchal, Haji
    Shapiro, Jeremy D.
    Robitaille, Sonia
    Price, Timothy J.
    Shepherd, Lois
    Au, Heather-Jane
    Langer, Christiane
    Moore, Malcolm J.
    Zalcberg, John R.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (17): : 1757 - 1765
  • [28] Predicting which lung cancer patients can benefit from tivozanib
    不详
    BIOMARKERS IN MEDICINE, 2010, 4 (06) : 839 - 839
  • [29] More patients can benefit from existing breast cancer drugs
    Printz, Carrie
    CANCER, 2013, 119 (08) : 1449 - 1449
  • [30] Can lifestyle changes affect the progression of prostate cancer? Results from the prostate cancer lifestyle trial
    Weidner, G
    PSYCHOLOGY & HEALTH, 2005, 20 : 288 - 289
12345